Skip to main content
. Author manuscript; available in PMC: 2016 Dec 10.
Published in final edited form as: J Control Release. 2015 Sep 28;219:383–395. doi: 10.1016/j.jconrel.2015.09.056

Fig. 8.

Fig. 8

Schematic illustration of a representative camptothecin drug amphiphile (DA). (A) The self-assembled nanostructures contain the same drug content as that of the individual DA. (B) Illustration of the three key components: the hydrophobic drug CPT, Tau-β-sheet-forming peptide, and the buSS biodegradable linker (or using a non-degradable amine linker). RP-HPLC trace (C) and MALDI-Tof mass spectrum (D) of the mCPT-buSS-Tau DA to reveal high purify and monodispersity in molecular mass.